from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1584c/-

LFCtreatmentdescriptionclass of inhibitor

-0.371

Amikacinug/mL Amikacintranslation

-0.070

Cap5-10ug/mL Capreomycintranslation

0.067

Rox10-50 ug/mL Roxithromycintranslation

0.047

SM2-5 ug/mL Streptomycintranslation

0.936

Tet5-10 ug/mL Tetracyclinetranslation

-0.757

Rif0.2-5ug/mL Rifampicintranscription

-0.664

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.216

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.180

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.319

CPZ10-50 ug/mL Chlorpromazinerespiration

0.242

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.338

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.628

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.801

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.228

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.443

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.076

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.534

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.527

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.055

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.617

KCN5-20 ug/mL Potassium cyaniderespiration

0.039

NaN30.2-2 mM Sodium aziderespiration

-0.748

Nigericin50 uM Nigericinrespiration

0.237

TRC10-150 ug/mL Triclosanrespiration

1.425

TRZ10-25 ug/mL Thioridazinerespiration

4.069

Valinomycin0.5-10 uM Valinomycinrespiration

-0.352

ZnSO42 mM ZnSO4respiration

-0.340

menadione6-10 ug/mL Menadionerespiration

-0.635

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.611

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.415

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.507

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.238

NRP_1Non-replicating persistence stage 1dosRassociated

-0.328

Amp0.2mg/mL AmpicillincellWall

-0.201

Cephalexin20-100 ug/mL CephalexincellWall

-0.291

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.841

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.543

EMB10-20 ug/mL EthambutolcellWall

-0.185

Eta12-40 ug/mL EthionamidecellWall

-0.290

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.298

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.486

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.274

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.520

BZA0.12 mg/mL BenzamidearomaticAmides

0.253

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.636

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.446

H2O24 mM hydrogen peroxideDNAdamaging

-0.067

Levo10 ug/mL LevofloxacinDNAdamaging

-0.456

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.148

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.362

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.719

UVUV-irradiationDNAdamaging

1.193

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.806

Antimycin12.5-50 ug/mL Antimycin A?

-0.513

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.786

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.343

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.734

PA8240.2-2 ug/mL PA-824?

0.733

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.284

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.172

Verapamil50 uM Verapamil?

-0.600

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.265

methoxatin10-20 ug/mL Methoxatin?